Literature DB >> 19631973

Role of omalizumab and steroids in Churg-Strauss syndrome.

Maria Francesca Spina, Antonio Miadonna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19631973     DOI： 10.1016/j.jaci.2009.05.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases.

Authors:  Zeynep Celebi Sozener; Begum Gorgulu; Dilsad Mungan; Betul Ayse Sin; Zeynep Misirligil; Omur Aydin; Sevim Bavbek
Journal:  World Allergy Organ J       Date:  2018-12-03       Impact factor: 4.084

3.  Anti-cytokine targeted therapies for ANCA-associated vasculitis.

Authors:  Malgorzata M Bala; Teresa J Malecka-Massalska; Magdalena Koperny; Joanna F Zajac; Jarosław D Jarczewski; Wojciech Szczeklik
Journal:  Cochrane Database Syst Rev       Date:  2020-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.